| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
LINC02210-CRHR1 readthrough | 0.570 | 0.692 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2018 | 2018 | |||||||||
|
promyelocytic leukemia | 0.477 | 0.846 | 0.21 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2018 | 2018 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
long intergenic non-protein coding RNA 1720 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||
|
myosin IF | 0.722 | 0.385 | 2.4E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
NADH:ubiquinone oxidoreductase subunit S4 | 0.587 | 0.808 | 3.1E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
natriuretic peptide receptor 3 | 0.633 | 0.615 | 1.0E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
parkin RBR E3 ubiquitin protein ligase | 0.431 | 0.846 | 6.9E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
heterochromatin protein 1 binding protein 3 | 0.805 | 0.154 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
PBX homeobox 2 | 0.686 | 0.462 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
phospholipase C epsilon 1 | 0.572 | 0.654 | 5.7E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
Kruppel like factor 13 | 0.674 | 0.577 | 0.40 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
GIPC PDZ domain containing family member 2 | 0.736 | 0.423 | 3.2E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
GATA zinc finger domain containing 2A | 0.792 | 0.231 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
VPS53 subunit of GARP complex | 0.659 | 0.654 | 1.4E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
coiled-coil domain containing 91 | 0.729 | 0.423 | 3.8E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
muskelin 1 | 0.769 | 0.269 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
myocyte enhancer factor 2C | 0.517 | 0.769 | 1.7E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
major histocompatibility complex, class II, DR alpha | 0.581 | 0.769 | 0.52 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
homeobox A11 | 0.568 | 0.692 | 0.94 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
integrin subunit beta 8 | 0.650 | 0.462 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
H2A clustered histone 9, pseudogene | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 |